Denali Therapeutics Inc (DNLI)
22.29
+4.01%
Denali Therapeutics Inc (DNLI) is currently trading at $22.29. This represents a gain of 4.01% from the previous session. With a market capitalization of $3.47B, DNLI is a key component of the Health Care sector. Investors looking to trade DNLI should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade DNLI commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Denali Therapeutics Inc (DNLI) shows a bullish trend. Analysts are watching the 22.59 level closely.
Fundamentals
Mkt Cap3.47B
P/E Ratio0.0000
Volume1,636,866
60-Day Technical Chart
Advanced Charting
Need more indicators for DNLI? Use the world's #1 platform.
Open DNLI on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $22
| Metric |
DNLI +4.01% |
BMNR +10.60% |
HL -1.40% |
NCLH -0.63% |
|---|---|---|---|---|
| Price | $22.29 | $21.51 | $23.31 | $23.81 |
| Mkt Cap | $3.47B | $9.80B | $15.63B | $10.82B |
| - | View → | View → | View → |
Latest Headlines
Denali Therapeutics Inc. (DNLI) Stock Analysis: Strong Buy Ratings Signal a 57% Potential Upside
DirectorsTalk Interviews • Feb 24, 2026
$DNLI stock is down 11% today. Here's what we see in our data.
Quiver Quantitative • Dec 10, 2025
Denali Therapeutics (NASDAQ: DNLI) prices $200M equity deal at $17.50
Stock Titan • Dec 10, 2025
Denali Therapeutics stock falls after announcing $200 million public offering
Investing.com • Dec 9, 2025
H.C. Wainwright Reiterates “Buy” Rating on Denali Therapeutics (DNLI) With $32 PT Following Q3 Results
Yahoo Finance • Nov 10, 2025
● Gemini Agentic AI Analyst Insight for DNLI
Market Education
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Investors.com Inspired - Top 50 Stocks for 2024 Jun 11, 2023
- Penny Stock List Nov 19, 2023
External Research